Who backs Ascend (Drug Discovery)?
13 investors| Investor | Type |
|---|---|
| DCVC | Venture capital |
| Cathay Capital | PE / buyout |
| Digitalis Ventures | Venture capital |
| Deerfield Management | Venture capital |
| DCVC Bio | Venture capital |
| Lingotto | Hedge fund |
| EW Healthcare Partners | Venture capital |
| 4BIO Capital | — |
| Abingworth | — |
| Ajinomoto | — |
| + 3 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Ascend (Drug Discovery)
- ·The full record, as it builds
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 13 firms already write checks for companies like Ascend (Drug Discovery). Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.